Publication
Article
BioPharm International
Author(s):
by Denise Wendt The Court's decision not to allow the patenting of higher life forms puts it at odds with Japan, europe, and the United States.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.